14 January 2019, Stockholm, Sweden. Lipidor AB, a Swedish drug development company with an ongoing fully financed Phase III study for a psoriasis medication, has successfully completed a private placement of 20 MSEK from Swedish and international investors. “We have received very positive feedback from both current and new investors on our outlooks as well […]
Stockholm, Sweden 4 October: Psoriasis is a chronic disease affecting 2-4% of the world’s population. A new anti-psoriasis spray now in a Phase III trial offers more comfort to patients, and improves dose control. The first patient has now entered the trial. Lipidor’s Calcipotriol Spray is being evaluated over 8 weeks of treatment in a […]
India’s CDSCO (Central Drugs Standard Control Organization) has approved Phase III Trials of a new topical anti-psoriatic spray developed by Swedish company Lipidor. The new spray is expected to overcome patient non-compliance, a major problem for traditional psoriasis creams and ointments. It is exceptionally fast-drying and easy to apply. Calcipotriol Spray consists of the generic […]